Gene Query: NEPRO

Dataset Description Geneva Score
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 17.46
Identifying the molecular mode of action of itraconazole in colorectal cancer 14.93
RNA sequencing of matched nephrectomy samples [RNA-seq] 13.8
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 13.8
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 13.21
IDH3a KO RNA-seq 10.76
RNA-seq analysis of BAP1-depleted uveal melanoma cells 10.56
Rorc disruption in human FG pancreatic cancer cells 9.94
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 9.67
hTERT promotes cell adhesion and migration independent of telomerase activity 9.6
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 9.54
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 9.0
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 8.75
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 8.52
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 8.13
RNA-seq of YB5 cells treated with Proscillaridin A 8.05
Human cell line and subcutaneous tumor 8.04
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 7.99
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 7.86
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 7.78
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 7.38
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 7.37
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 7.36
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 7.33
The evolution of N6-methyladenosine in primates 7.2
Co-transcriptional loading of RNA export factors shapes the human transcriptome 7.08
RNAseq of HEK293 cells after Chtop knockdown 7.08
Nucleoporin-mediated regulation of cell identity genes 7.04
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 7.03
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 6.81
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 6.78
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 6.75
Global Mapping of Human RNA-RNA Interactions 6.74
R430: A potent inbibitor of DNA and RNA viruses 6.72
MYC dependent mRNA translation shapes gene expression and cell biology 6.67
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 6.65
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 6.65
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 6.63
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 6.56
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 6.56
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 6.46
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 6.34
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 6.28
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 6.18
Hepatosplenic T cell lymphoma 6.18
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 6.18
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 6.05
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 6.03
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 6.01
Effect of mitochondria deficiency on senescence-associated gene expression 5.99
An integrative analysis of non-coding regulatory DNA variations associated with autism 5.97
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 5.84
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 5.82
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 5.82
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 5.78
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 5.74
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 5.74
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 5.7
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 5.68
Tracking distinct RNA populations using efficient and reversible covalent chemistry 5.65
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 5.6
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 5.54
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 5.53
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 5.5
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 5.5
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 5.48
Transcriptomic analyssis following EHMT1/2 inhibition 5.4
Single-nucleotide-resolution mapping of HBV promoters using CAGE 5.39
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 5.32
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 5.32
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 5.32
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 5.27
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 5.25
MicroRNA-125a-5p overexpression in human macrophages 5.25
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 5.19
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 5.19
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 5.16
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 5.15
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 5.13
SLIGRL-induced gene expression changes in NHEK cells 5.11
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 5.1
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.09
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 5.07
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 5.07
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 4.98
Control of prostate tumour growth by the long non-coding RNA GHSROS 4.96
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 4.96
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 4.95
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 4.93
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 4.9
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 4.88
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 4.88
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 4.86
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 4.85
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 4.78
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 4.74
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 4.73
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 4.7
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 4.7
Effect of PRDM11 depletion in U2932 cells 4.69
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 4.68
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 4.64
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 4.63
single cell RNA-seq from GM12878 (ENCSR673UIY) 4.61
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 4.6
Dtx3L and Androgen Signaling in Prostate Cancer 4.5
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 4.49
3’ Uridylation Expands miRNA Target Repertoire 4.49
Inhibition of TNBC metastasis by Gpx1 4.47
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 4.46
Tyrosine Kinase Inhibitor Cardiotoxicity 4.44
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 4.44
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 4.44
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 4.44
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 4.43
Biological effect of chronic mistranslation in mammalian cells 4.43
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 4.4
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 4.36
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 4.36
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 4.35
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 4.35
Peptidomimetic blockade of MYB in acute myeloid leukemia 4.34
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 4.34
RNA expression analysis upon JMJD1C depletion 4.31
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 4.31
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 4.29
Seletive inhibition of CDK9 in DLBCL cell lines 4.27
Identification of a LIF-responsive replication-competent human β cell 4.27
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 4.25
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 4.23
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 4.23
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 4.19
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 4.19
Cajal bodies are linked to genome conformation [RNA-Seq] 4.19
Cajal bodies are linked to genome conformation 4.19
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 4.18
Lysine benzoylation is a novel histone mark 4.18
Lysine benzoylation is a novel histone mark [RNA-seq] 4.18
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 4.17
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 4.15
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 4.15
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 4.14
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 4.14
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 4.1
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 4.06
Gene expression in GBM with Cav3.2 inhibition 4.06
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 4.03
Endothelial gene expression analysis 4.03
Cellular response to hepatitis E virus (HEV) infection 4.02
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 3.97
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 3.95
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 3.93
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 3.93
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 3.92
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 3.92
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 3.91
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 3.89
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.89
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 3.84
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 3.84
Human embryonic stem cells in E8 and AKIT culture medium 3.84
Molecular Criteria for Defining the Naive Human Pluripotent State 3.83
LINE-2 transposable elements are a source of functional human microRNAs and target sites 3.83
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 3.8
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 3.8
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 3.78
SETBP1-WT and SETBP1-G870S epigenetic landscapes 3.77
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 3.77
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 3.76
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 3.76
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 3.75
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 3.74
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 3.73
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 3.68
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 3.68
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 3.68
In vitro modeling of human germ cell development using pluripotent stem cells 3.65
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 3.62
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 3.6
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 3.6
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 3.58
Mapping interactions for the TNIP2 hub protein 3.58
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 3.57
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 3.56
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 3.54
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 3.52
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 3.52
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 3.52
RNA sequencing of human mammary epithelial cells 3.51
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 3.51
Zika infected neural stem cells 3.5
Transcriptome analysis of Zika infected neural stem cells 3.5
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 3.5
ARID1A regulates condensin II distribution and chromosomal partition 3.49
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 3.49
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 3.46
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 3.46
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 3.46
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 3.44
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 3.44
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 3.44
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.42
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 3.42
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 3.4
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 3.4
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 3.4
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 3.37
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 3.27
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 3.27
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 3.26
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 3.23
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 3.22
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 3.19
IRF1 regulates IFN dependent and independent gene expression 3.18
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.16
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.16
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 3.16
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 3.16
MYCL and EP400 are required for Max and MCPyV mediated gene activation 3.15
Effect of drugs on transcriptomic profiles 3.13
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 3.11
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 3.11
Noncoding regions are the main source of targetable tumor-specific antigens 3.11
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 3.1
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 3.1
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 3.1
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 3.1
Identification of global XBP1s target gene expression in human prostate cancer cells 3.08
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 3.04
Transcription control by the ENL YEATS domain in acute leukemia 3.04
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 2.99
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 2.98
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 2.98
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 2.97
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 2.96
Global transcriptome analysis of HAP1 cells 2.96
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 2.95
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 2.95
Stem and effector CD8 T-cells from human cancers 2.91
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 2.9
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 2.9
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 2.9
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 2.9
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 2.88
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 2.86
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 2.85
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 2.85
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 2.84
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 2.84
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 2.83
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.81
Gene expression profile in breast cancer cells 2.81
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 2.81
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 2.81
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 2.79
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 2.78
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 2.75
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 2.74
RNA-seq of RKO cells with cTAZ KO or putback 2.7
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 2.67
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 2.67
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 2.66
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.65
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.64
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.63
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 2.62
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 2.61
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 2.58
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 2.56
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 2.56
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 2.56
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 2.55
N6-methyladenine DNA Modification in Glioblastoma 2.55
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 2.54
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 2.53
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 2.51
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 2.51
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 2.51
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 2.51
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 2.5
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.48
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 2.48
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 2.48
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 2.47
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 2.45
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.44
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 2.44
Systematic discovery of endogenous human ribonucleoprotein complexes 2.43
Chromatin-informed inference of transcriptional programs in gynecologic cancers 2.43
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 2.43
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 2.43
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.42
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.42
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 2.42
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.4
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 2.37
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 2.37
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 2.36
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 2.36
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 2.36
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 2.35
Hepatitis C virus functionally sequesters miR-122 2.35
CD73 knockdown effect in pancreatic cancer cell lines 2.34
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 2.34
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 2.34
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 2.33
DRB/GRO-Seq -/+ UV 2.3
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 2.29
Induced DNA demethylation, genome instability and transcription 2.29
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 2.29
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 2.28
RNA-Seq of PRMT1 overexpression ECA109 cells 2.25
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.25
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 2.25
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 2.23
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 2.22
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 2.22
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 2.18
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 2.15
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 2.15
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.13
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.13
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 2.1
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 2.1
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 2.09
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 2.08
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 2.07
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 2.04
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 1.98
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 1.96
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 1.96
O-glcnAc reprograms cellular energetics 1.91
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 1.85
MCF-7 as a model for functional analysis of breast cancer risk variants 1.84
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 1.83
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.83
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.82
RNA-Seq from human ILC transitional populations 1.82
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 1.82
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 1.8
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 1.79
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.79
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.79
Real-time observation of light-controlled transcription in living cells 1.79
SLAM-seq for K562 endogenous mRNA decay 1.78
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 1.68
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.64
Human HAP1 cells before and after nutrient deprivation 1.64
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 1.64
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 1.64
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 1.64
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 1.61
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 1.61
Controlling for gene expression changes in transcription factor protein networks. 1.57
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 1.56
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 1.52
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 1.52
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 1.51
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.5
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 1.5
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 1.49
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.47
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 1.47
naive T cell heterogeneity after neonatal thymectomy 1.43
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 1.43
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.42
The circadian transcriptional landscape in primary human mammary epithelial cells 1.42
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.41
Expression charcaterization of an internal protocol developed to differentiate RPE cells 1.4
Transcriptional landscape changes during human embryonic stem cell derivation 1.36
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.36
Dynamic 3D chromosomal landscapes in acute leukemia 1.35
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 1.35
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.34
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 1.33
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 1.33
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.33
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.28
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.28
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 1.27
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.27
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.27
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.27
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.26
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.26
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.26
Functional significance of the HIV-1 Tat signature amino acid residues 1.24
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 1.23
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 1.22
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 1.22
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 1.21
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.21
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.2
Role of COP1 on MAP kinase transcriptional output in melanoma 1.18
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 1.12
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.12
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 1.11
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 1.1
FOXP1 orchestration of ASD-relevant signaling pathways. 1.08
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 1.08
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.07
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 1.06
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.05
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.05
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  1.03
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.96
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 0.91
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 0.91
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.91
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.9
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.89
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.88
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.88
The transcriptome and chromatin accessbility landscape of mammalian germline 0.87
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.8
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 0.79
The cohesin release factor WAPL restricts chromatin loop extension. 0.79
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.79
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.77
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 0.76
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.76
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.75
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.74
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.71
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 0.69
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 0.66
An optimization system for isolating and sequencing of single human colon cancer cells 0.66
p53 activity results in DNA replication fork processivity 0.65
HBEC-shp53-PCHD7 0.64
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.63
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 0.6
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.59
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 0.59
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.57
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.54
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.51
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.49
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 0.49
Loss of CREBBP results in gene expression repression in lymphoma cells 0.48
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.48
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.48
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.48
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.48
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.48
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.48
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.47
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.46
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.45
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.44
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.44
Transcriptome-wide modulation of splicing by the exon junction complex 0.44
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.41
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.41
Modulation of nonsense-mediated decay by rapamycin 0.41
Myc activation coordinates gene transcription and protein translation responses 0.4
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.39
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.38
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.38
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 0.38
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.38
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.37
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.36
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.35
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.34
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.28
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.26
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.24
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.23
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.21
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.21
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.21
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.2
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.18
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.16
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.14
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 0.13
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.13
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.1
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.1
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.09
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.09
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.07
Microglia innatly develop within cerebral organoids 0.06
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 0.05
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.05
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.05
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.05
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.04
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 0.04
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 0.04
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.04
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.04
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.03
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.02
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.02
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.01
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.01
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.01
Function and hormonal regulation of GATA3 in human first trimester placentation 0.01
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation